Clinical Trials
487
Active:22
Completed:413
Trial Phases
4 Phases
Phase 1:144
Phase 2:101
Phase 3:186
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (451 trials with phase data)β’ Click on a phase to view related trials
Phase 3
186 (41.2%)Phase 1
144 (31.9%)Phase 2
101 (22.4%)Phase 4
20 (4.4%)A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants
- First Posted Date
- 2020-04-01
- Last Posted Date
- 2023-06-29
- Target Recruit Count
- 15
- Registration Number
- NCT04330248
- Locations
- π§πͺ
Clinical Pharmacology Unit, Merksem, Belgium
A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2014-06-25
- Target Recruit Count
- 32
- Registration Number
- NCT02103985
A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2014-01-30
- Target Recruit Count
- 6
- Registration Number
- NCT02049697
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2014-01-24
- Target Recruit Count
- 88
- Registration Number
- NCT02023255
A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2013-12-24
- Target Recruit Count
- 64
- Registration Number
- NCT02019485
- Prev
- 1
- 2
- 3
- 4
- 5
- 93
- Next
News
No news found